1342 studies found for:    "Thrombosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Thrombosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Anticoagulation Length in Cancer Associated Thrombosis
Conditions: Cancer;   Thrombosis;   Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolus
Intervention: Drug: Low Molecular Weight Heparin (LMWH)
2 Unknown  Rosuvastatin for Preventing Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Venous;   Thrombosis;   Prevention
Interventions: Drug: Rosuvastatin 20mg/d for 14days;   Drug: enoxaparin only
3 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
4 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
5 Completed
Has Results
Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Device: DVT-3000;   Device: SCD Express
6 Completed
Has Results
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
Conditions: Thrombosis, Venous;   Acute Deep Vein Thrombosis
Interventions: Drug: Fondaparinux sodium;   Drug: unfractionated heparin (UFH)
7 Completed Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
Conditions: Thrombosis;   Thromboembolism;   Venous Thrombosis
Intervention: Drug: Tinzaparin sodium
8 Completed A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate;   Drug: enoxaparin/unfractionated heparin;   Drug: warfarin
9 Active, not recruiting Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care
10 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
11 Terminated Anticoagulation Post Laparoscopic Splenectomy
Conditions: Portal Vein Thrombosis;   Splenic Vein Thrombosis
Intervention: Drug: Enoxaparin
12 Completed Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism;   Thromboembolism;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b);   Drug: low molecular weight heparin/unfractionated heparin;   Drug: warfarin
13 Recruiting Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
Conditions: Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions: Drug: BAY 59-7939;   Drug: ASA
14 Unknown  Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
15 Completed 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism;   Deep Vein Thrombosis With Pulmonary Embolism
Interventions: Drug: Duration of anticoagulation;   Drug: Warfarin duration
16 Completed Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
Conditions: Thrombosis;   Thromboembolism;   Venous Thrombosis
Intervention: Drug: Tinzaparin sodium
17 Withdrawn Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Rosuvastatin (AZD4522);   Drug: Placebo
18 Completed Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: warfarin accordingly INR value
19 Completed Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: Warfarin
20 Recruiting Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
Condition: Sinus Thrombosis, Intracranial
Interventions: Drug: Endovascular thrombolysis;   Drug: Heparin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years